ELSILIMOMAB
UNII DGK38A42AE

Substance Identification & Data

This profile provides standardized clinical and technical data for Elsilimomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DGK38A42AE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 468715-71-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DGK38A42AE
CAS Registry Number
468715-71-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ELSILIMOMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8371
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elsilimomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELSILIMOMAB

Common Names & Synonyms

ANTIBODY B-E8
ANTI-IL-6 MAB B-E8
B-E8
ELSILIMOMAB [INN]
ELSILIMOMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6) (MOUSE HYBRIDOMA B-E8 .KAPPA.-CHAIN)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6) (MOUSE MONOCLONAL B-E8 HEAVY CHAIN), DISULFIDE WITH MOUSE MONOCLONAL B-E8 K-CHAIN, DIMER
MAB B-E8